Cenobamate (ONTOZRY®), for the Treatment of Drug-Resistant Focal-Onset Seizures in Adults, Is Now Available in the Netherlands
Cenobamate use results in unprecedented seizure freedom rates for patients 1 PARIS–(BUSINESS WIRE)– Angelini Pharma, international pharmaceutical company part of the privately held Italian Angelini...